Tyra Biosciences Inc (TYRA)
15.36
-0.51
(-3.21%)
USD |
NASDAQ |
Nov 21, 16:00
16.12
+0.76
(+4.95%)
After-Hours: 20:00
Tyra Biosciences Enterprise Value: 442.94M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 442.94M |
| November 19, 2024 | 460.14M |
| November 18, 2024 | 422.70M |
| November 15, 2024 | 418.65M |
| November 14, 2024 | 466.72M |
| November 13, 2024 | 436.36M |
| November 12, 2024 | 446.48M |
| November 11, 2024 | 461.16M |
| November 08, 2024 | 455.08M |
| November 07, 2024 | 507.71M |
| November 06, 2024 | 506.19M |
| November 05, 2024 | 487.98M |
| November 04, 2024 | 470.77M |
| November 01, 2024 | 506.44M |
| October 31, 2024 | 521.77M |
| October 30, 2024 | 484.23M |
| October 29, 2024 | 533.93M |
| October 28, 2024 | 691.49M |
| October 25, 2024 | 799.35M |
| October 24, 2024 | 1.153B |
| October 23, 2024 | 1.133B |
| October 22, 2024 | 1.129B |
| October 21, 2024 | 1.140B |
| October 18, 2024 | 1.085B |
| October 17, 2024 | 1.013B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.009B |
| October 15, 2024 | 933.11M |
| October 14, 2024 | 804.11M |
| October 11, 2024 | 799.88M |
| October 10, 2024 | 749.12M |
| October 09, 2024 | 765.51M |
| October 08, 2024 | 784.02M |
| October 07, 2024 | 741.72M |
| October 04, 2024 | 805.16M |
| October 03, 2024 | 780.84M |
| October 02, 2024 | 823.14M |
| October 01, 2024 | 847.46M |
| September 30, 2024 | 882.89M |
| September 27, 2024 | 858.70M |
| September 26, 2024 | 861.87M |
| September 25, 2024 | 855.53M |
| September 24, 2024 | 876.12M |
| September 23, 2024 | 874.54M |
| September 20, 2024 | 912.56M |
| September 19, 2024 | 893.02M |
| September 18, 2024 | 851.31M |
| September 17, 2024 | 806.95M |
| September 16, 2024 | 690.25M |
| September 13, 2024 | 747.81M |
| September 12, 2024 | 711.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-72.83M
Minimum
Jun 17 2022
1.153B
Maximum
Oct 24 2024
365.04M
Average
361.80M
Median
Enterprise Value Benchmarks
| Amgen Inc | 206.13B |
| Johnson & Johnson | 384.09B |
| PROCEPT BioRobotics Corp | 4.870B |
| NovaBay Pharmaceuticals Inc | 2.745M |
| Palatin Technologies Inc | 15.49M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.02M |
| Total Expenses (Quarterly) | 28.60M |
| EPS Diluted (Quarterly) | -0.41 |
| Earnings Yield | -10.47% |